Patents by Inventor Joel Vacus

Joel Vacus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200281873
    Abstract: The present invention is in the field of therapeutic drugs to treat leishmaniasis. In particular, the invention concerns adamantane and bicyclic monoterpenoid derivatives for use in the treatment of leishmaniasis.
    Type: Application
    Filed: October 31, 2018
    Publication date: September 10, 2020
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, Université Paris-Sud, Drugabilis
    Inventors: Daniel Gillet, Jean-Christophe Cintrat, Julien Barbier, Alain Pruvost, Philippe Loiseau, Joël Vacus
  • Patent number: 8344145
    Abstract: The invention relates to salts of 2-substituted quinolines, the manufacturing method for same, and use of the same for the production of drugs. Said salts are advantageous in that the same can be obtained in crystalline form, which facilitates their implementation in the manufacture of pharmaceutical compositions.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: January 1, 2013
    Assignee: Institut de Recherche pour le Developpement
    Inventors: Alain Fournet, Nashira Campos Vieira, Bruno Figadere, Blandine Seon Meniel, Joël Vacus, Philippe Loiseau, Rodolphe Baudoin
  • Publication number: 20110144154
    Abstract: The invention relates to salts of 2-substituted quinolines, the manufacturing method for same, and use of the same for the production of drugs. Said salts are advantageous in that the same can be obtained in crystalline form, which facilitates their implementation in the manufacture of pharmaceutical compositions.
    Type: Application
    Filed: April 14, 2009
    Publication date: June 16, 2011
    Inventors: Alain Fournet, Nashira Campos Vieira, Bruno Figadere, Blandine Seon Meniel, Joël Vacus, Philippe Loiseau, Rodolphe Baudoin
  • Patent number: 6187746
    Abstract: The present invention relates to injectable compositions containing a dalfopristine/quinupristine combination comprising an aqueous solution containing the dalfopristine/quinopristine combination and an additive intended to avoid or reduce the intolerance effects at the site of injection.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: February 13, 2001
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Guillaume Conrath, Joël Vacus, Nicholas Paul Barker
  • Patent number: 6156338
    Abstract: The invention concerns a method for preparing a composition for transferring nucleic acids consisting in contacting a nucleic acid with a cationic lipid, whereby, previous to contacting, the cationic lipid is subjected to a heating step. The invention also concerns the resulting compositions and their use.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: December 5, 2000
    Assignee: Aventis Pharma S.A.
    Inventors: Joel Vacus, Tsiala Bouknikachvili
  • Patent number: 6146663
    Abstract: This invention relates to stabilized nanoparticles which may be filtered under sterile conditions, comprising at least one hydrophobic, water-insoluble and non-water-dispersible polymer or copolymer (and optionally an active principle) which is emulsified in an aqueous solution or suspension comprising a phospholipid and a bile salt.
    Type: Grant
    Filed: September 9, 1997
    Date of Patent: November 14, 2000
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Marie-Christine Bissery, Michel Laborie, Joel Vacus, Thierry Verrecchia